STAAB THOMAS R II bought TENX
May 11, 2026 · Form 4 insider transaction
STAAB THOMAS R II bought 450,000 shares of Tenax Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
450,000
Price
$0.00
Total value
N/A
InsiderSTAAB THOMAS R II
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 11, 2026
Filing dateMay 13, 2026
Shares owned after450,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options vest and become exercisable as follows: 25% vest on May 11, 2027, and thereafter, the remainder vest in substantially equal installments on each monthly anniversary of the grant date for a period of 36 months, subject to the Reporting Person's continued employment.